AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 46 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $923,000 | -77.7% | 348,499 | +18.6% | 0.00% | -100.0% |
| Q1 2018 | $4,137,000 | +744.3% | 293,839 | +605.3% | 0.00% | – |
| Q4 2017 | $490,000 | +42.4% | 41,659 | +71.6% | 0.00% | – |
| Q3 2017 | $344,000 | +144.0% | 24,275 | +142.8% | 0.00% | – |
| Q2 2017 | $141,000 | -81.7% | 10,000 | -78.3% | 0.00% | – |
| Q1 2017 | $770,000 | +62.1% | 46,100 | +60.1% | 0.00% | – |
| Q4 2016 | $475,000 | -54.7% | 28,800 | -63.3% | 0.00% | – |
| Q3 2016 | $1,049,000 | +568.2% | 78,500 | +229.3% | 0.00% | – |
| Q2 2016 | $157,000 | – | 23,839 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 400,900 | $1,062,000 | 0.78% |
| EMORY UNIVERSITY | 209,207 | $554,000 | 0.37% |
| EcoR1 Capital, LLC | 1,150,000 | $3,048,000 | 0.29% |
| Baker Brothers Advisors | 10,934,154 | $28,976,000 | 0.22% |
| DLD Asset Management, LP | 763,100 | $2,030,000 | 0.15% |
| UNIVERSITY OF NOTRE DAME DU LAC | 214,759 | $569,000 | 0.11% |
| Kalos Management, Inc. | 15,850 | $226,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 257,613 | $683,000 | 0.09% |
| DLD Asset Management, LP | 379,900 | $1,007,000 | 0.08% |
| DLD Asset Management, LP | 379,300 | $1,009,000 | 0.08% |